

Creador acquires 7% stake in pharma company La Renon
Subscribe to enjoy similar stories. Mumbai: Kuala Lumpur-based private equity firm Creador has acquired a 7% stake in La Renon Healthcare from the promoter and existing investor Peak XV Partners for an undisclosed sum, the companies said in a statement on Monday. Creador’s purchase of shares from Peak XV comes about a decade after the venture capital firm first invested in the company.
While the promoter family continues to hold a controlling stake, the transaction marks Creador's continued focus on high-quality healthcare and pharmaceutical companies. Its other investments in healthcare include Accumax Lab Devices and Paras Healthcare. “We are delighted to partner with Pankaj and the entire La Renon team as they enter their next phase of growth," said Anshul Agarwal, co-head at Creador India.
Founded in 2007 by Pankaj Singh, La Renon is a prominent player in India’s branded formulations market with a strong presence in nephrology, neurology, and other chronic segments. Over the years, the company has built a strong reputation for its differentiated product portfolio and has attracted investment from firms, including A91 Partners (invested in 2021) and ChrysCapital (2024) Other backers including Avendus, White Oak Capital and Siguler Guff that invested into the company through this year. “Creador’s investment marks a major milestone in the company’s rapid growth journey and reflects a strong confidence in its performance track record," said Singh, founder and managing director of La Renon.
Citadel Management Consulting acted as the financial advisor to La Renon on this transaction. The Ahmedabad-based pharmaceutical company has delivered a 25% CAGR in revenue and 30% CAGR in Ebitda over the last 10 years. In FY25, it
. Read on livemint.com